Multi‐institutional nomogram predicting benign prostate pathology on magnetic resonance/ultrasound fusion biopsy in men with a prior negative 12‐core systematic biopsy

• Published in: Cancer Vol. 124; no. 2; pp. 278 - 285
• Main Authors: Truong, Matthew, Wang, Bokai, Gordetsky, Jennifer B., Nix, Jeffrey W., Frye, Thomas P., Messing, Edward M., Thomas, John V., Feng, Changyong, Rais‐Bahrami, Soroush
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 15.01.2018
• Subjects: Benign; Biopsy; Cancer; Decision analysis; Decision theory; diagnostic imaging; early detection of cancer; Health care facilities; Magnetic resonance imaging; Multivariate analysis; NMR; Nomograms; Nuclear magnetic resonance; Oncology; Pathology; Patients; Prostate; Prostate cancer; Prostate-specific antigen; prostatic neoplasms; Resonance; Ultrasonic imaging; Ultrasound; magnetic resonance imaging; early detection of cancer; nomograms; diagnostic imaging; prostatic neoplasms

BACKGROUND Prostate multiparametric magnetic resonance imaging (mpMRI) may be recommended for patients with a prior negative systematic biopsy (SB). However, a proportion of these patients will continue to have no prostate cancer (PCa) identified on magnetic resonance/ultrasound fusion biopsy (FB) d...